Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia.
Engervall
P
P
Division of Hematology and Infectious Diseases at the Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Kalin
M
M
Björkholm
M
M
D000038:Abscess / Q000188:drug therapy / Q000382:microbiology; D000307:Adrenal Gland Diseases / Q000188:drug therapy / Q000382:microbiology; D000368:Aged; D000583:Amikacin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D014376:Tuberculosis / Q000188:drug therapy*; D014386:Tuberculosis, Hepatic / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000995:Antitubercular Agents; D003561:Cytarabine; D000583:Amikacin; D003630:Daunorubicin